Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Hepatitis

voriconazole has been researched along with Hepatitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, M; Hasegawa, Y; Hashimoto, N; Ishigami, M; Majima, S; Okachi, S; Sato, M; Wakahara, K1
Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E1
Bäsecke, J; Glass, B; Perske, C; Rüchel, R1

Other Studies

3 other study(ies) available for voriconazole and Hepatitis

ArticleYear
Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome.
    Internal medicine (Tokyo, Japan), 2018, Aug-15, Volume: 57, Issue:16

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchoalveolar Lavage Fluid; Female; Hepatitis; Humans; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Trachea; Treatment Outcome; Voriconazole

2018
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9

    Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole

2003
A case of pulmonary aspergillosis with lack of response to caspofungin.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole

2006